Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer
Bladder cancer is one of the more common cancers worldwide. It is considered a major health care problem with a high financial burden. Of these cases, 75% are non-muscle-invasive, which characterizes dangerous diseases with ...